Close Menu

NEW YORK (GenomeWeb) – OpGen announced today it has partnered with the New York State Department of Health and Ilúm Health Solutions, a subsidiary of Merck's Healthcare Services and Solutions, to build an antimicrobial resistance tracking tool for the state healthcare system.

OpGen will receive a $1.5 million contract for a 12-month demonstration portion of the project, according to a statement, with potential for full implementation during the next five years, depending on meeting certain milestones. Further terms of the partnership were not disclosed

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.

Feb
20
Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.